fashion -WSS

fashion

author：focus 2025-10-01 15:29:23 - browse：82

SAN DIEGO — One of the toughest subtypes of acute leukemia involves a genetic alteration in the KMT2A gene. Many cancers with this genetic alteration end up relapsing or don’t respond to treatment, but new data presented at the annual American Society of Hematology meeting offer hope of a new targeted therapy for these patients.

The study, called the Phase 2 Augment-101 trial, tested Syndax’s revumenib in patients with relapsed or refractory leukemia with these KMT2A genetic rearrangements. Overall, about 63% of the patients responded to the treatment, with many able to receive a potentially curative stem cell transplant later on, which is often the ultimate goal for patients with relapsed or refractory patients, said Ibrahim Aldoss, a hematologist-oncologist at City of Hope and the study’s presenter, in an interview.

“KMT2A-rearranged diseases represent 10% of all leukemia. They can be exceptionally hard to treat,” Aldoss said. “The median overall survival remains low with current available treatment. Right now there’s no targeted therapy for KMT2A-rearranged disease. We’re really excited about revumenib as it targets the mutation, and we’re seeing encouraging outcomes.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： California Joshua trees severely burned in massive wildfire

explore

WSS

Teen charged with murder as hate crime in killing of NYC dancer O'Shae Sibley: Sources

IVF doctors demand details after CooperSurgical lawsuit

Families look for replacement for GSK asthma drug Flovent

Ancient Greek ideas underpin modern concepts of pregnancy

Jailed Russian opposition leader Alexey Navalny gets 19 more years in prison

Why Talkspace is targeting Medicare, a tricky market

knowledge

fashion

focus

Cancer drug shortages should be causing more outrage

Stem cell biologist probes earliest stages of human development

Peter Hotez and the public health issue of online harassment

IVF doctors demand details after CooperSurgical lawsuit

New air purifier tech could be key to improving indoor air quality

New company forms to vet health AI models, root out weaknesses

Heart attack and stroke risk calculators need revising

Pharma needs to include young adults in clinical research

Cancer drug shortages should be causing more outrage

Tuesday set an unofficial record for the hottest day on Earth. Wednesday may break it.

explore

Jesse Tyler Ferguson makes friendship bracelets for Taylor Swift's Eras Tour

Harvard's David Sinclair gets blowback over aging

Scientists find bacteria from stomach of ancient iceman

Climate activists disrupt London Pride march to protest corporate sponsorship

US Marines prepare to be put on commercial ships to deter Iranian harassment in Strait of Hormuz

What to know about 'Guardians of the Galaxy Vol. 3' as it hits Disney+

focus

leisure time

explore

knowledge